Results 11 to 20 of about 701 (80)

ФАРМАКОДИНАМИЧЕСКИЕ ЭФФЕКТЫ КАРДИОСЕЛЕКТИВНОГО В-АДРЕНОБЛОКАТОРА НЕБИВОЛОЛА У БОЛЬНЫХ ИШЕМИЧЕСКОЙ БОЛЕЗНЬЮ СЕРДЦА И МЕТАБОЛИЧЕСКИМ СИНДРОМОМ [PDF]

Евразийский Кардиологический Журнал, 2019
Бета-адреноблокаторы (БАБ) рекомендуются большинству больных с различными формами ишемической болезни сердца (ИБС), однако их применение зачастую ограничивается различными факторами, в частности неблагоприятным метаболическим профилем. Цель.

doaj   +2 more sources

Beta-blockers and chronic kidney disease: a literature review [PDF]

Качественная клиническая практика
Chronic kidney disease (CKD) and cardiovascular diseases are widespread throughout the world and are closely related to each other. Sympathetic hyperactivity, characteristic of CKD, increases cardiovascular risk and accelerates the progression of kidney ...
I. E. Bachmakov, A. N. Fedoseev, V. E. Denisova   +2 more
doaj   +3 more sources

Заболевания щитовидной железы. Диффузный токсический зоб [PDF]

, 2007
ЗОБ ДИФФУЗНЫЙ ТОКСИЧЕСКИЙЩИТОВИДНОЙ ЖЕЛЕЗЫ ...
Abdullahel Hadi, Abdur Razzaque, Ali Ashraf, Asaria P, Bahl VK, Barker DJP, Bonita R, Boutayeb A, Boutayeb A, Dalstra JA, De Gregorio J, Ghaffar A, Gupta R, Harding JE, Hill D, Hoang Van Minh, Hussain A, Hussain A, Kabir ZN, Kanjilal S, Krishnan A, Kusol Soonthornthada, Medhi GK, Mehan MB, Minh HV, Minh HV, Miranda JJ, Mohan V, Nawi Ng, Ng N, Ng N, Reyes L, Rugg SS, Sanjay Juvekar, Sarrafzadegan N, Syed Masud Ahmed, TIPS (The Indian Polycap Study), Tran Huu Bich, Uraiwan Kanungsukkasem, WHO (World Health Organization), WHO (World Health Organization), WHO (World Health Organization), Yach D, Yusuf S, Zaman MM   +44 more
core   +4 more sources

TREATMENT OF HYPERTENSION IN PREGNANCY: GUIDELINES AND CLINICAL EXPERIENCE

Рациональная фармакотерапия в кардиологии, 2015
Topical issues of the treatment of hypertension in pregnancy are presented. Examples from clinical practice are discussed as well as possible medical treatment of hypertension in pregnant women taking into account actual recommendations.
O. V. Gaisenok, O. A. Zamyatina, N. Yu. Denisova, A. S. Leonov   +3 more
doaj   +1 more source

BETA-BLOCKERS IN THE TREATMENT OF ARTERIAL HYPERTENSION: EVIDENCE BASED DATA AND REAL PRACTICE

Рациональная фармакотерапия в кардиологии, 2015
Data of the largest meta-analyzes of beta-blockers use in arterial hypertension is presented. The role of beta-blockers among other basic groups of antihypertensive drugs (thiazide diuretics, calcium channel blockers, ACE inhibitors) is evaluated ...
M. V. Leonova
doaj   +1 more source

HIGH SELECTIVE LONG-ACTING Β1-BLOCKER WITH A VASODILATING EFFECT NEBIVOLOL IN PATIENTS WITH CHRONIC ISCHEMIC HEART DISEASE

Рациональная фармакотерапия в кардиологии, 2015
Review is devoted to the role of modern beta-blocker nebivolol in the treatment of stable ischemic heart disease (IHD). The mode of nebivolol anti-ischemic activity is considered, as well as its use particularities in IHD patients with different ...
V. P. Lupanov
doaj   +1 more source

COMPARISON OF THE METABOLIC EFFECTS OF CARVEDILOL AND METОPROLOL IN HYPERTENSIVE PATIENTS WITH OVERWEIGHT AND OBESITY. THE CAMELLIA TRIAL

Рациональная фармакотерапия в кардиологии, 2016
Aim. To compare two therapies based on carvedilol or metoprolol in hypertensive patients with overweight and obesity.Material and methods. 320 patients with arterial hypertension (1-2 degree) were involved in the study.
S. Y. Martsevich, N. P. Kutishenko, E. V. Shilova, A. D. Deev, S. A. Shalnova, R. G. Oganov, I. A. Veliganina, E. G. Volkova, Yu. E. Voskanjan, L. I. Gapon, P Ya. Dovgalevskij, V. Ya. Ermolina, E. M. Idrisova, N. N. Ilov, A. R. Kiselev, S. Yu. Levashov, V. A. Nevzorova, G. I. Nechaeva, T. N. Panova, I. I. Reznik, V. V. Skibickij, L. A. Sokolova, V. P. Terentev, N. V. Hailo, A. V. Shabalin, T. V. Shnjukova, V. V. Yakusevich   +26 more
doaj   +1 more source

IZUChENIE PLEYOTROPNYKh EFFEKTOV V-ADRENOBLOKATOROV I INGIBITOROV APF NA KOSTNUYu TKAN'

Остеопороз и остеопатии, 2014
Objective: To investigate the effect of treatment with betablockers (β-AB), inhibitors of angiotensin converting enzyme (ACEI) on bone mineral density (BMD) depending on the risk factors (RF) of osteoporosis. Material and methods.
I A SKRIPNIKOVA, K E SOBChENKO, E S ABIROVA, V E NOVIKOV, T V POPKOVA, I S DYDYKINA, V A VYGODIN, A V SMIRNOV   +7 more
doaj   +1 more source

Adherence to Visits to Medical Institutions and Quality of Therapy after Acute Coronary Syndrome (according to the LIS Registry 3) [PDF]

, 2023
Aim. The aim of the research is to evaluate the relationship between patients' adherence to visiting polyclinics after acute coronary syndrome (ACS) and the quality of the therapy they receive.Material and methods. The study was conducted on the basis of
A. V. Zagrebelny, M. L. Ginzburg, N. P. Zolotareva, O. M. Drapkina, S. Yu. Martsevich   +4 more
core   +2 more sources

Блокаторы бета-адренорецепторов в терапевтической клинике [PDF]

, 2008
Описана клиническая фармакология бета-адреноблокаторов в рамках классификационной системы АТС. Дана клиническая классификация и особенности фармакокинетики и фармакодинамики препаратов данной группы.
Макиенко, Н.В., Мартимьянова, Л.А., Усань, Н.Ю.   +2 more
core